glp 1 agonist anesthesia GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the perioperative setting. These aGLP-1 receptor agonists & anesthesia:

Another study also demonstrated that depletion of Treg cells could increase the area of delayed cerebral infarction and further exacerbate neurofunctional damage (78)

Semaglutides, such as Ozempic and Wegovy, are one type of GLP-1 drug

doi: 10.1210/jcem-64-1-190 [DOI] [PubMed] [Google Scholar] 20

Exercising regularly, eating more fiber and drinking lots of water

Hydrophobic interactions between Phe 9 and Y152 1.47 and L141 1.36 anchor the peptide to GLP-1R in both a conformer 1-like structure (beginning of the video) and a conformer 2-like structure (end of the video) during the simulation

Common ZEPBOUND side effects include nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, injection site reactions, fatigue, allergic responses, belching, hair loss, and heartburn, though this is not an exhaustive list of potential ZEPBOUND side effects